When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Thinly traded nano cap VistaGen Therapeutics (OTC:VTGN-44.8%) slumps on almost a 5x surge in volume in reaction to the unsuccessful outcome of an exploratory Phase 2 clinical trial assessing lead candidate AV-101 as monotherapy in patients with treatment-resistant depression.
More news on: VistaGen Therapeutics, Inc., Healthcare stocks news, Stocks on the move,